M&T Bank’s Amedisys AMED Stock Holding History

M&T Bank’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,928	Closed	-$386K	–	1485
2025 Q2	$386K	Buy	3,928 +514	+15%	+$48.6K	﹤0.01%	1170
2025 Q1	$315K	Buy	+3,414	New	+$315K	﹤0.01%	1241
2021 Q3	–	Sell	-830	Closed	-$203K	–	1569
2021 Q2	$203K	Hold	830	–	–	﹤0.01%	1457
2021 Q1	$220K	Sell	830 -489	-37%	-$138K	﹤0.01%	1374
2020 Q4	$387K	Buy	1,319 +146	+12%	+$37.4K	﹤0.01%	1197
2020 Q3	$278K	Buy	+1,173	New	+$267K	﹤0.01%	1274
2017 Q1	–	Sell	-10,242	Closed	-$436K	–	1666
2016 Q4	$436K	Buy	10,242 +1,729	+20%	+$73.5K	﹤0.01%	1112
2016 Q3	$404K	Buy	8,513 +2,213	+35%	+$110K	﹤0.01%	1134
2016 Q2	$318K	Sell	6,300 -1,297	-17%	-$65.5K	﹤0.01%	1210
2016 Q1	$367K	Buy	+7,597	New	+$293K	﹤0.01%	1179

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

M&T Bank's AMED Position: Q3 2025 in Review

M&T Bank sold out of Amedisys (AMED) in Q3 2025, closing a stake of 3,928 shares — an estimated $386K sold.

M&T Bank first reported a position in AMED in Q1 2016 and held it in 10 quarters. The position peaked at $436K in Q4 2016. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

M&T Bank reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
M&T Bank sold 3,928 Amedisys shares in Q3 2025, an estimated $386K.
M&T Bank first reported a position in Amedisys in Q1 2016 and held it in 10 quarters.
M&T Bank's Amedisys position peaked at $436K in Q4 2016.
4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on M&T Bank's 13F filing for Q3 2025, filed 14 Nov 2025.